Trial Profile
A study of RP101 for the treatment of chronic Dry Eye Disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs RP 101-Redwood Pharma (Primary)
- Indications Dry eyes
- Focus Adverse reactions; Therapeutic Use
- 01 Mar 2016 New trial record